AVAILABILITY OF ANTIBODIES

Availability

The Human Protein Atlas project use both commercial and non-commercial antibodies. In case commercial antibodies have been used to generate data, a link to the antibody provider website and product name is provided at the "Antibody validation" page for each gene/protein, click the provider name under Antibody information to be directed to the company’s website. There may be cases where the antibody has been discontinued by the provider. In case the antibody is provided by an academic source, please contact us for further information on contact@proteinatlas.org.

Abbot Laboratories
Abcam plc
AbD Serotec
AbFrontier
Abgent
Abnova
Affinity BioReagents
Alomone Labs
Alpha Diagnostic
Apotech Corp.
ARETA international
Atlas Antibodies
Austrian Academy of Sciences
Becton Dickinson
BioGenex
BioLegend
BioPorto Diagnostics A/S
BioSource
Caltag
CapitalBio Corp.
Cell Marque
Cell Signaling Technology, Inc
Chemicon
Covance
DakoCytomation
ECM Biosciences
Enzo Life Sciences
Epitomics
GeneTex
GenWay Biotech
Harvard Medical School
HUPO-liver
Insitute Curie, France
Karolinska Institute
Karolinska Institute MBB
Kazusa DNA Research Institute
Lab Vision/NeoMarkers
LifeSpan Biosciences
MBL
Medical University of Vienna
Merck Millipore
Molecular Probes
Monash University MATF
National Institutes of Health
NCI-CPTC
Novocastra
Novus Biologicals
Oncogene Research Products
Origene
Oviedo University, Spain
Pharmingen
PROGEN Biotechnik
Promega
Proteintech Group Inc
QED Bioscience
R&D Systems
R-Biopharm AG
Roche
Rockland
Santa Cruz Biotechnology
SDIX
SIGMA
Sigma-Aldrich
Synaptic Systems GmbH
Södertörns University College
Thermo Fisher Scientific
Transduction laboratories
University College London (UCL) Medical School
University of Glasgow
University of Gothenburg
University of Hawaii at Manoa
University of New Mexico
University of Tampere
University of Toronto
University of Tromsö
University Pablo de Olavide, Sevilla
Uppsala University ICM
Uppsala University IMBIM
Uppsala University LICR
Upstate
Vicgene Biotechnology
Zymed